John Hiemenz - Concepedia

Concepedia

Author

John Hiemenz

National Cancer Institute

Also Known As

J H Hiemenz, JOHN HIEMENZ, John Hiemenz

34

Publications

3.3K

Citations

15

H-Index

22

Concepts

All Affiliations

National Cancer Institute University of Florida National Institutes of Health Moffitt Cancer Center Vanderbilt University

JH

About

John Hiemenz is an author at National Cancer Institute specializing in medicine, drug resistance, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	265
2	Immunology	2	2	62
3	Pharmacology	2	2	105
4	Cellular Therapies	1	1	32
5	Marrow Transplantation	1	1	32

John Hiemenz

×

15

Publications

3.3K

Citations

15

H-Index

	Year	Citations
Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and Neutropenia Thomas J. Walsh, Robert W. Finberg, Carola Arndt, New England Journal of Medicine	1999	1.2K
A Randomized Trial Comparing Ceftazidime Alone with Combination Antibiotic Therapy in Cancer Patients with Fever and Neutropenia Philip A. Pizzo, James W. Hathorn, John Hiemenz, New England Journal of Medicine	1986	593
A Double-Blind Comparison of Empirical Oral and Intravenous Antibiotic Therapy for Low-Risk Febrile Patients with Neutropenia during Cancer Chemotherapy Alison G. Freifeld, Donna Marchigiani, Thomas J. Walsh, New England Journal of Medicine	1999	401
Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven Aspergillosis John R. Wingard, Paul Kubilis, Lily Lee, Clinical Infectious Diseases	1999	360
Amphotericin B lipid complex in pediatric patients with invasive fungal infections Thomas J. Walsh, Nita L. Seibel, Carola Arndt, The Pediatric Infectious Disease Journal	1999	158
Approaching the controversies in antibacterial management of cancer patients Philip A. Pizzo, James R. Commers, Deborah Cotton, The American Journal of Medicine OncologyAntibioticsAntimicrobial StewardshipAntibacterial AgentAntimicrobial Therapy	1984	128
Perspective on the management of catheterrelated infections in cancer patients John Hiemenz, Jane Skelton, Philip A. Pizzo The Pediatric Infectious Disease Journal	1986	113
Population pharmacokinetics of micafungin in adult patients Tawanda Gumbo, John Hiemenz, Lei Ma, Diagnostic Microbiology and Infectious Disease PharmacologyPharmacotherapyAntimicrobial PharmacokineticsPopulation PharmacokineticsMedicine	2007	75
Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile. Karen K. Fields, Gerald J. Elfenbein, Hillard M. Lazarus, Journal of Clinical Oncology	1995	70
Motixafortide and G-CSF to mobilize hematopoietic stem cells for autologous transplantation in multiple myeloma: a randomized phase 3 trial Zachary Crees, Michael P. Rettig, Reyka G. Jayasinghe, Nature Medicine	2023	68

Page 1